What is the ROE (Return on Equity) of Ibio this year?
The ROE of Ibio this year is -4.22 undefined.
Ibio ROE 2024
Ibio ROE
-4.22
Ticker
IBIO
ISIN
US4510332038
WKN
A2JNBU
In 2024, Ibio's return on equity (ROE) was -4.22, a 431.97% increase from the -0.79 ROE in the previous year.
Ibio Aktienanalyse
What does Ibio do?
Ibio Inc is a US biopharmaceutical company founded in 2008. It is headquartered in Bryan, Texas and employs approximately 130 employees. The company is listed on the New York Stock Exchange (NYSE: IBIO). The business model of Ibio Inc is to develop innovative biopharmaceutical products and sell them in the market. The company utilizes plant expression systems technology to extract proteins and antibodies from plant cells, which significantly reduces production costs, allowing for cost-efficient manufacturing of rare and expensive medications. The company is divided into various divisions, including research and development, manufacturing of biopharmaceuticals, and vaccine production. In the research and development field, Ibio Inc focuses on innovative products in oncology and infectious diseases. One example of their products is IBIO-100, which is intended for the treatment of breast and prostate cancer. Another product of Ibio Inc is IBIO-CFB03, a vaccine against COVID-19 produced using plant expression technology. In 2020, the company formed a partnership with the Brazilian biotech company CC-Pharming Ltda. for this vaccine. Additionally, Ibio Inc is involved in the production of biopharmaceuticals, including various antibodies used in the treatment of cancer. One example is IBIO-101, a monoclonal antibody against the tumor protein folate receptor alpha, which can be used in the therapy of ovarian, breast, and lung cancer. The company collaborates closely with various partners in the pharmaceutical industry to bring its products to the market. This includes working with CC-Pharming, with whom they developed the COVID-19 vaccine, as well as Chinese biotech company CC-Pharming Shanghai Co. Ltd., which serves as a production partner for Ibio Inc. Ibio Inc is an innovative company that enables cost-efficient production of biopharmaceuticals through the use of plant expression technology. The company primarily focuses on oncology and infectious diseases and collaborates with partners in the pharmaceutical industry to bring its products to the market. Ibio ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Ibio's Return on Equity (ROE)
Ibio's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Ibio's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Ibio's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Ibio’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Ibio stock
How has the Return on Equity (ROE) of Ibio developed compared to the previous year?
The ROE of Ibio has increased by 431.97% increased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Ibio?
A high ROE indicates that Ibio generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Ibio?
A low ROE can indicate that Ibio is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Ibio affect the company?
A change in ROE (Return on Equity) of Ibio can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Ibio?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Ibio?
Some factors that can influence Ibio's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Ibio pay?
Over the past 12 months, Ibio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ibio is expected to pay a dividend of 0 USD.
What is the dividend yield of Ibio?
The current dividend yield of Ibio is .
When does Ibio pay dividends?
Ibio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Ibio?
Ibio paid dividends every year for the past 0 years.
What is the dividend of Ibio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Ibio located?
Ibio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Ibio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Ibio from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.
When did Ibio pay the last dividend?
The last dividend was paid out on 9/19/2024.
What was the dividend of Ibio in the year 2023?
In the year 2023, Ibio distributed 0 USD as dividends.
In which currency does Ibio pay out the dividend?
The dividends of Ibio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Ibio
Our stock analysis for Ibio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ibio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
